No Conflicting Rights. The Company shall not, on or after the date hereof, grant any registration or similar rights to any Person or amend any existing registration or similar rights previously granted by the Company, if such grant or amendment would conflict with or impair in any material respect the rights granted hereby.
No Conflicting Rights. The Issuer represents and warrants that no other Person has registration rights that conflict with the rights granted to the Holders hereunder.
No Conflicting Rights. The Company shall not, on or after the date hereof, grant any registration or similar rights to any Person which conflict with or impair the rights granted hereby other than, without limiting the provisions of Section 12.3, the Investor Registration Agreement in the form filed with this Agreement on the date hereof with the Bankruptcy Court.
No Conflicting Rights. The holders of the outstanding capital stock of the Company are not entitled to pre-emptive or other rights to subscribe for the Securities.
No Conflicting Rights. As from the Effective Date and for the duration of the Term, Takeda will not, and will cause its Affiliates not to, grant to any Third Party rights in the Field in the Licensee Territory that encumber, diminish, or conflict with the rights granted to Licensee hereunder with respect to the Takeda Regulatory Materials or Takeda Technology.
No Conflicting Rights. From and after the Combined Territories License Agreement Effective Date, neither Party will grant any right to any Third Party relating to its respective technology in the Field which would conflict with the rights granted to the other Party hereunder.
No Conflicting Rights. As of the date of this Agreement, the Company has not granted registration rights to any Person other than the registration rights provided for by this Agreement to the Holders. The Company shall not (a) grant any registration rights to third parties which are more favorable than or inconsistent with the rights granted hereunder, or (b) enter into any agreement, take any action, or permit any change to occur, with respect to its securities that violates or subordinates the rights expressly granted to the Holders of Registrable Securities in this Agreement. The Company agrees that in no event will the Company effect, or permit to be effected, an initial public offering of the Company’s business through any parent or subsidiary of the Company or any other entity other than the Company.
No Conflicting Rights. Solvay has not granted, and will not grant during the term of this Agreement, any right to any Affiliate or Third Party which would conflict with the rights granted to Jazz Pharmaceuticals hereunder. Solvay will not take, or cause or permit any Affiliate or Third Party to take, any action that will conflict with, contravene or otherwise limit or restrict the rights of Jazz Pharmaceuticals hereunder or the right of Jazz Pharmaceuticals to enjoy the benefits of this Agreement.
No Conflicting Rights. The holders of the outstanding capital stock of the Company are not entitled to pre-emptive or other rights to subscribe for the Units. The offering of the Units as contemplated by the Memorandum does not give rise to any rights relating to the registration of any outstanding capital stock.
No Conflicting Rights. The holders of the outstanding capital stock of the Company are not entitled to pre-emptive or other rights to subscribe for Preferred Shares. Other than as set forth in the Memorandum, the offering of the Preferred Shares as contemplated by the Memorandum does not give rise to any rights relating to the registration of any outstanding capital stock.
